0 participants
A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-09-28
- Start Date:
- 2022-04-15
- Completion:
- 2025-03-15
Conditions
- Chemotherapy-Induced Thrombocytopenia
Interventions
- DRUG
No Results Yet